Wave Life Sciences: Peers

The FY2024 (Dec) proxy of Wave Life Sciences names 15 peer companies for pay. Among Wave Life Sciences and these peers, CEO pay was the lowest of 7 and total shareholder return was the highest of 7.

7th highest of 7in Wave Life Sciences and its pay peers, FY2024 (Dec) by CEO pay:

$4.3M$15.4M

1st highest of 7in Wave Life Sciences and its pay peers, FY2024 (Dec) by total shareholder return:

$58$157

Pay peer group, FY2024 (Dec) proxy

Ionis Pharmaceuticals
Intellia Therapeutics
PTC Therapeutics
Denali Therapeutics
Beam Therapeutics
Stoke Therapeutics
Alector, Inc.Not disclosedNot disclosed
Arcturus Therapeutics Holdings, Inc.Not disclosedNot disclosed
Arrowhead PharmaceuticalsNot disclosedNot disclosed
Avidity Biosciences, Inc.Not disclosedNot disclosed
Dyne TherapeuticsNot disclosedNot disclosed
Editas Medicine, Inc.Not disclosedNot disclosed
Prime Medicine, Inc.Not disclosedNot disclosed
Sangamo TherapeuticsNot disclosedNot disclosed
Verve Therapeutics, Inc.Not disclosedNot disclosed
15 companies

Changes by year

No proxy on file names a change to the peer group.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.